Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Volkmann

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
The European Respiratory Journal|February 22, 2020
Predictors of progression in systemic sclerosis patients with interstitial lung diseaseOliver Distler, Shervin Assassi, Vincent Cottin, et al.
Arthritis Care & Research|August 4, 2025
International Investigation of the Gut-Lung Axis in Systemic Sclerosis-Interstitial Lung DiseaseKristofer Andréasson, Arissa Young, Swapna Joshi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association of Systemic Sclerosis With a Unique Colonic Microbial ConsortiumElizabeth R Volkmann, Yu-Ling Chang, Nashla Barroso, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
BMJ Open Gastroenterology|August 2, 2017
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohortsElizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, et al.
Respiratory Research|December 31, 2024
Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi studyAthol U Wells, Simon L F Walsh, Ayodeji Adegunsoye, et al.
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.
Arthritis Research & Therapy|April 11, 2025
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana J Bernstein, Shawn E Cowper, et al.
Journal of Scleroderma and Related Disorders|June 19, 2026
Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"Zsuzsanna H McMahan, Maria Cristina De Santis, Anna Lo Cricchio, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
The European Respiratory Journal|February 22, 2020
Predictors of progression in systemic sclerosis patients with interstitial lung diseaseOliver Distler, Shervin Assassi, Vincent Cottin, et al.
Arthritis Care & Research|August 4, 2025
International Investigation of the Gut-Lung Axis in Systemic Sclerosis-Interstitial Lung DiseaseKristofer Andréasson, Arissa Young, Swapna Joshi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association of Systemic Sclerosis With a Unique Colonic Microbial ConsortiumElizabeth R Volkmann, Yu-Ling Chang, Nashla Barroso, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
BMJ Open Gastroenterology|August 2, 2017
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohortsElizabeth R Volkmann, Anna-Maria Hoffmann-Vold, Yu-Ling Chang, et al.
Respiratory Research|December 31, 2024
Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi studyAthol U Wells, Simon L F Walsh, Ayodeji Adegunsoye, et al.
Annals of the Rheumatic Diseases|November 10, 2018
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohortsElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2019
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18Elizabeth R Volkmann, Donald P Tashkin, Masataka Kuwana, et al.
Arthritis Research & Therapy|April 11, 2025
Neural network analysis as a novel skin outcome in a trial of belumosudil in patients with systemic sclerosisIlayda Gunes, Elana J Bernstein, Shawn E Cowper, et al.
Journal of Scleroderma and Related Disorders|June 19, 2026
Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee"Zsuzsanna H McMahan, Maria Cristina De Santis, Anna Lo Cricchio, et al.
Pageof 20